Infinity Announces the Date of Its First Quarter 2013 Financial Results Conference Call and Webcast

Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Infinity Pharmaceuticals, Inc. (INFI) will host a conference call on Tuesday, May 7, 2013, at 4:30 p.m. ET. During the call, management will provide an update on Infinity's business and discuss the company's first quarter 2013 financial results.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 32689466. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at www.infi.com.

Contact:
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Kate.Murray@infi.com
http://www.infi.com
View Comments